Status:
UNKNOWN
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
Lead Sponsor:
Federal University of Minas Gerais
Conditions:
Open-Angle Glaucoma
Surgery
Eligibility:
All Genders
40+ years
Phase:
PHASE2
PHASE3
Brief Summary
The study has the purpose to evaluate the effectiveness and safety of the goniocurettage as a first choice of surgical treatment for primary open-angle glaucoma (POAG) in patients with good vision.
Detailed Description
A prospective study in 33 eyes (32 patients) with uncontrolled open angle glaucoma under clinical treatment. The trabecular tissue was scraped away from the angle (goniocurettage) in about 100 degrees...
Eligibility Criteria
Inclusion
- Disc and/or visual field findings consistent with Primary Open Angle Glaucoma
- Uncontrolled intraocular pressure (≥21 mm Hg) or progressive glaucomatous neuropathy despite maximum tolerated medical therapy
- 40 years old or over
- Visual acuity higher than 0.2
- Open angles (greater or equal to Shaffer grade II)
Exclusion
- Previous ocular surgery
- History of glaucoma laser treatment
- History of ocular trauma
- Cyclodestructive procedures
- Corneal edema or opacities
- Endothelial decompensation
- History of uveitis
- Secondary glaucoma
- neovascularization of the iris or angle
- Congenital anterior segment abnormalities
- Anatomically confusing angles without clear definition of the scleral spur or meshwork and inability to maintain follow-up
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01511094
Start Date
June 1 2009
End Date
January 1 2012
Last Update
January 18 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, Brazil, 30130-100